Evidence map›Paper›PMID 30670737›Full record

ArticleScientific reports2019

Mendelian randomization provides support for obesity as a risk factor for meningioma.

Hannah Takahashi, Alex J Cornish, Amit Sud, Philip J Law, Linden Disney-Hogg, Lisa Calvocoressi, Lingeng Lu, Helen M Hansen, Ivan Smirnov, Kyle M Walsh and 12 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. PleiotropicNeuro-oncology advances
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 5 countries.

Hannah TakahashiDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Alex J CornishDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. alex.cornish@icr.ac.uk.ORCID 0000-0002-3966-3501
Amit SudDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0002-6133-0164
Philip J LawDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0001-9663-4611
Linden Disney-HoggDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Lisa CalvocoressiSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Lingeng LuSchool of Public Health, Yale University, New Haven, Connecticut, USA.ORCID 0000-0001-9871-0809
Helen M HansenDivision of Neuroepidemiology, Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
Ivan SmirnovDivision of Neuroepidemiology, Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
Kyle M WalshDivision of Neuroepidemiology, Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
Johannes SchrammUniversity of Bonn Medical School, Bonn, Germany.
Per HoffmannHuman Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.
Markus M NöthenDepartment of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
Karl-Heinz JöckelInstitute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Joellen M SchildkrautDepartment of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
Matthias SimonUniversity of Bonn Medical School, Bonn, Germany.
Melissa BondySection of Epidemiology and Population Sciences, Department of Medicine and Dan L., Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Margaret WrenschDivision of Neuroepidemiology, Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
Joseph L WiemelsDivision of Neuroepidemiology, Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
Elizabeth B ClausSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Clare TurnbullDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Richard S HoulstonDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Institute of Cancer Research · GBUniversity of California, San Francisco · USUniversity of Bonn · DEYale University · USBaylor College of Medicine · USBrigham and Women's Hospital · USUniversity of Duisburg-Essen · DEUniversity of Virginia · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Cancer Research UK C1298/A8362Wellcome Trust
6 · The paper itself

Abstract

Little is known about the causes of meningioma. Obesity and obesity-related traits have been reported in several epidemiological observational studies to be risk factors for meningioma. We performed an analysis of genetic variants associated with obesity-related traits to assess the relationship with meningioma risk using Mendelian randomization (MR), an approach unaffected by biases from temporal variability and reverse causation that might have affected earlier investigations. We considered 11 obesity-related traits, identified genetic instruments for these factors, and assessed their association with meningioma risk using data from a genome-wide association study comprising 1,606 meningioma patients and 9,823 controls. To evaluate the causal relationship between the obesity-related traits and meningioma risk, we consider the estimated odds ratio (OR) of meningioma for each genetic instrument. We identified positive associations between body mass index (odds ratio [OR

Indexed as

Adipose TissueBody Mass IndexCase-Control StudiesGenetic VariationGenome-Wide Association StudyHumansMendelian Randomization AnalysisMeningiomaObesityOdds RatioRisk Factors

Identifiers

PMID30670737
PMCPMC6343031
OpenAlexW2914971573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.